PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 14, 2011Journal of Pharmacy and Pharmacology27 citationsOpen Access

Oltipraz therapy in patients with liver fibrosis or cirrhosis: a randomized, double-blind, placebo-controlled phase II trial

View Full Paper
SKSang Geon KimYKYoung Mi KimJCJong Young Choi

Key Points

Key points are not available for this paper at this time.

Abstract

No significant differences in liver histological outcomes were seen among the three treatment groups in this 24-week pilot study. Our finding indicates an association between TGF-β1 repression and improvement in the histological index of fibrosis.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kim et al. (2011) studied this question.

synapsesocial.com/papers/69dc0a4a5a07db3dcf37497bhttps://doi.org/10.1111/j.2042-7158.2011.01259.x
Ask AI
Helpful
Bookmark
Share
View Full Paper